ENBA SRL
4.8 FTEThe score of ENBA shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +48 % Total assets +22 % Headcount (avg FTE) -4 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
ENBA's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 103,367 € | ||||
| Equity | 824,275 € | ||||
| Cash | 623,973 € | ||||
| EBITDA | 233,984 € | ||||
| Total assets | €1.48m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 07 Jul 2026
- Year ended 31 Dec 2024filed on 13 Jun 2025
- Year ended 31 Dec 2023filed on 13 Aug 2024
- Year ended 31 Dec 2022filed on 12 Jun 2023
- Year ended 31 Dec 2021filed on 13 Jun 2022
ENBA's financial analysis
- Solvency55.7%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of ENBA
ENBA's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0440.845.501
- VAT number
- BE0440845501
- Peppol
- Registered · 0208:0440845501 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 07 Jun 1990
- Registered office
- 2820 Bonheiden
- Size
- Micro · 4.8 FTE
- Latest accounts
- 2025 · filed on 07 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
ENBA (SRL) has been based in Bonheiden since 1990, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 103,367 € and equity of 824,275 €; its revenue is not published. With 4.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 55.7%, above the median of its sector (44.2%).
Companies similar to ENBA
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Orban Retail sale of pharmaceutical products Woluwe-Saint-Pierre · balance sheet €1.48m
- Apotheek Vanclooster Retail sale of pharmaceutical products Lanaken · balance sheet €1.48m
- VAN Holder Stephan Retail sale of pharmaceutical products Zottegem · balance sheet €1.48m
- D5-Pharma Retail sale of pharmaceutical products Ganshoren · balance sheet €1.49m
- Marephar Retail sale of pharmaceutical products Lichtervelde · balance sheet €1.49m
- HDS - Farma Retail sale of pharmaceutical products Erpe-Mere · balance sheet €1.46m
- DE Luchthaven Apotheek Retail sale of pharmaceutical products Zaventem · balance sheet €1.50m
- Alpha pharma Retail sale of pharmaceutical products Roeselare · balance sheet €1.45m
Frequently asked questions about ENBA
What is the revenue of ENBA?
ENBA files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of ENBA?
In Belgium, the VAT number is the company number prefixed with BE: BE0440845501 for ENBA, if the company is VAT-registered. Its company number (CBE) is 0440.845.501.
Where is the registered office of ENBA?
According to the CBE register, the registered office of ENBA is in 2820 Bonheiden.
What is the equity of ENBA?
At the close of the 2025 financial year, the equity of ENBA amounts to 824,275 €, a solvency of 55.7% of total assets.
How many people work at ENBA?
4.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages ENBA?
The register lists 2 active mandates at ENBA. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of ENBA
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →